Michael Andriole

Algemeen Directeur bij CHIMERIX, INC.

Vermogen: 398 296 $ op 30-04-2024

51 jaar

Health Technology

Consumer Services

Actieve functies van Michael Andriole

Bedrijven	Functie	Begin	Einde
CHIMERIX, INC.	Directeur/Bestuurslid	01-08-2023	-
	Algemeen Directeur	01-08-2023	-
	President	01-08-2023	-
	Financieel Directeur/CFO	31-05-2019	01-08-2023
	Corporate Officer/Principal	08-04-2019	31-05-2019

Bedrijven	Functie	Begin	Einde
ENDOCYTE, INC.	Financieel Directeur/CFO	21-02-2017	01-12-2018
ELI LILLY AND COMPANY	Corporate Officer/Principal	01-08-2006	01-02-2017

Williams College of Business	Undergraduate Degree
Kelley School of Business	Masters Business Admin

Internationaal

Verenigde Staten

Operationeel

Director of Finance/CFO	2
Corporate Officer/Principal	2
Undergraduate Degree	1

Sectoraal

Health Technology	4
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
ELI LILLY AND COMPANY	Health Technology
CHIMERIX, INC.	Health Technology

Bedrijven in privébezit	1
Endocyte, Inc. Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.	Health Technology

Bedrijven in privébezit

Health Technology